Cargando…
Deregulation of protein phosphatase 2A inhibitor SET is associated with malignant progression in breast cancer
To understand the mechanism underlying metastasis, identification of a mechanism-based and common biomarker for circulating tumour cells (CTCs) in heterogenous breast cancer is needed. SET, an endogenous inhibitor of protein phosphatase 2A, was overexpressed in all subtypes of invasive breast carcin...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270961/ https://www.ncbi.nlm.nih.gov/pubmed/34244560 http://dx.doi.org/10.1038/s41598-021-93620-y |